Expertise Therapeutic Areas

Oncology

https://accelsiors.com/wp-content/uploads/2022/09/floating-blue-870x550px.png
https://accelsiors.com/wp-content/uploads/2022/09/floating-blue-870x550px.png

Clinical trials in oncology play a vital role in the discovery and development of therapeutic solutions for various types of cancer. They have the potential to introduce groundbreaking treatments that were previously unavailable, revolutionizing the field of oncology.

In recent years, there has been a shift from traditional organ-based studies focusing on cytotoxic chemotherapy to a more targeted approach. Biomarker-driven trials have emerged, utilizing molecularly targeted agents that interfere with crucial cell signaling mechanisms or immune responses to cancer in specific patient subsets. This paradigm shift emphasizes the significance of clinical trials in oncology.

Accelsiors recognizes and embraces the ongoing changes in scientific, methodological, practical, and patient-focused aspects of oncology trials.

We actively participate in the necessary transformation of these trials to stay at the forefront of advancements in the field. We understand that collaboration with key stakeholders is essential to establish a framework for next-generation clinical trials that balance operational efficiency, scientific impact, and value to patients.

Being part of efficiently changing the
oncology landscape

Ask Accelsiors' Clinical Trial Regulatory Experts
A male Oncologist of Middle Eastern decent sits with a senior patient as they discuss her medications.  The patient is dressed casually and wearing a head scarf to keep her warm as she looks at the tablet in the doctors hands, and her prescriptions can be seen sitting out on the exam table beside her.

The emergence of precision medicine has revolutionized the approach to cancer therapy, offering patient-specific treatments that were previously considered unattainable. This new paradigm is transforming the landscape of cancer research and treatment.

At the forefront of this movement are small biotech and specialty pharmaceutical companies, often comprised of a small team and a single molecule. These organizations possess groundbreaking ideas and innovative therapies that have the potential to change lives.

Accelsiors understands the significance of supporting these visionary companies on their journey from brilliant ideas to life-changing realities. Our expertise in clinical trials enables us to navigate the complex path of drug development and bring these innovative therapies to patients in need.

Through our comprehensive clinical trial solutions, we provide the necessary support to advance these cutting-edge treatments. From study design and project management to regulatory compliance and data analysis, we are dedicated to ensuring the success of your clinical trials.

We recognize the unique challenges faced by small biotech and specialty pharmaceutical companies and tailor our services to meet your specific needs. Our flexible and agile approach allows us to adapt to the dynamic nature of your organization and the evolving landscape of precision medicine.

Partnering with Accelsiors means gaining a trusted ally that is committed to translating your brilliant ideas into life-changing realities. Together, we can accelerate the development of patient-specific treatments and contribute to the advancement of precision medicine in the fight against cancer.

Explore how our clinical trial expertise can turn your vision into a reality.
Let us support you on your journey to revolutionize cancer therapy and improve patient outcomes.

Our Oncology Experience

https://accelsiors.com/wp-content/uploads/2023/06/TA-graphic1-oncology.png
  • Executed studies from phase I (first in human) to phase III (registration) trials
  • Detailed database of highly qualified oncology sites worldwide
  • Access to patients around the globe
  • Significant experience in translational science in the field of oncology
  • Depth of experience with population PK analysis in adult and pediatric population, including PK/PD modelling
  • Vast experience in various oncology indications
  • Experience in studies with intra-tumoral IMP administration
  • Experience in pediatric oncology studies
Indications
https://accelsiors.com/wp-content/uploads/2023/07/Oncology_INDICATIONS-1.png
Type of IMP
https://accelsiors.com/wp-content/uploads/2023/07/Oncology_TYPE-OF-IMP.png
Experience by Trial Phases
https://accelsiors.com/wp-content/uploads/2023/07/Oncology_EXPERIENCE-BY-TRIAL-PHASES.png
https://accelsiors.com/wp-content/uploads/2022/08/hexagon-left-3-1.png
https://accelsiors.com/wp-content/uploads/2022/08/hexagon-left-2.png

Let us accelerate your clinical drug development program!